and Function of Abdomen and Gastrointestinal Tract

Use:  may be used to empty gallbladder about 30 minutes (to 4 hours) before tracer injection in patients on prolonged fasting (gallbladder atony + retained bile and sludge) ← absence of endogenously produced CCK

Dose for hepatobiliary scintigraphy:

package insert: with slow IV injection of 0.01 µg/kg KINEVAC® over 3 minutes (concentration of 1 µg/mL) the response is too variable

preferred: IV infusion of 0.01 µg/kg KINEVAC® over 30–60 minutes

Useful in:

(a)   patient fasting > 24 hours / on total parenteral nutrition


(b)  acalculous cholecystitis


(c)  chronic GB dysfunction


(d)  GB ejection fraction

Side effect:   increase in biliary-to-bowel transit time, dizziness, flushing, nausea, abdominal cramps, urge to defecate


acute pancreatitis, acute cholecystitis, obstruction of cystic duct / CBD, appendicitis, peritonitis, pyloric stenosis, peptic ulcer


=  17 amino acid peptide amide

PENTAGASTRIN = acyl derivative of the biologic active C-terminal tetrapeptide amide

Produced in:   antral cells + G cells of pancreas

Released by:

(a)  vagal stimulation, gastric distension

(b)  short-chain alcohol: ethanol, propanol

(c)  amino acids: glycine, β-alanine

(d)  caffeine

(e)  hypercalcemia

mediated by neuroendocrine cholinergic reflexes

Inhibited by:   drop in pH of antral mucosa to < 3.5


@    Stomach:

(1)  stimulation of gastric HCl secretion from parietal cells, which in turn

(2)  increases pepsinogen production by chief cells through local reflex

(3)  increase in antral motility

(4)  trophic effect on gastric mucosa → parietal cell hyperplasia

@    Pancreas

(1)  strong increase in enzyme output

(2)  weakly stimulates fluid + bicarbonate output

(3)  stimulates insulin release

@    Liver

(1)  water + bicarbonate secretion

@    Intestine

(1)  stimulates secretion of Brunner glands

(2)  increases motility

@    Gallbladder

(1)  stimulates contraction

@    Esophagus

(1)  increases resting pressure of LES


Produced in:   α cells (and β cells) of pancreas

Released by:   low blood glucose levels


@    Intestines

(1)  lowers pressure of GE sphincter

(2)  hypotonic effect on duodenum > jejunum > stomach > colon

@    Hormones

(1)  releases catecholamines from adrenal gland → paralysation of intestinal smooth muscle

(2)  increases serum insulin + glucose levels → mobilization of hepatic glycogen

@    Biliary tract

(1)  increases bile flow

(2)  relaxes gallbladder + sphincter of Oddi

Dose for radiologic imaging:   1 mg maximum

◊  IV administration causes a quick response + rapid dissipation of action!

◊  IM administration prolongs onset + increases length of action!

Half-life:  3–6 min

Side effects:   nausea + vomiting, weakness, dizziness (delayed onset of 1.5–4.0 hours after IM administration)


(1)  hypersensitivity / allergy to glucagon: urticaria, periorbital edema, respiratory distress, hypotension, coronary artery spasm (?), circulatory arrest

(2)  known hypertensive response to glucagon

(3)  pheochromocytoma: glucagon stimulates release of catecholamines

(4)  insulinoma: insulin-releasing effect may result in hypoglycemia

(5)  glucagonoma

(6)  poorly controlled diabetes mellitus


=  27–amino acid polypeptide hormone

Produced in:   duodenal mucosa

Released by:   hydrogen ions providing a pH < 4.5 (usually increase in postprandial intraluminal acidity)

The physiologic effects of secretin include secretion of bicarbonate-rich fluid from pancreatic ductal cells and transient increase in the sphincter of Oddi tone, which improves depiction of the pancreatic duct.


@    Stomach

(1)  inhibits release of gastrin → ↓ in HCl secretion

(2)  stimulates pepsinogen secretion by chief cells (potent pepsigogue)

(3)  decreases gastric and duodenal motility + contraction of pyloric sphincter

@    Pancreas

(1)  increases alkaline bicarbonate-rich pancreatic secretions (NaHCO3 = sodium bicarbonate)

»  bicarbonate = 2 x as much carbonate (CO3) per sodium ion in sodium bicarbonate (NaHCO3) as in sodium carbonate (Na2CO3); crucial role in physiological pH buffering

(2)  weakly stimulates enzyme secretion

(3)  stimulates insulin release

@    Liver

(1)  stimulates water + HCO3- secretion (most potent choleretic)

@    Intestine

(1)  stimulates secretion of Brunner glands

(2)  inhibits motility

@    Esophagus

(1)  opens LES

@    Sphincter of Oddi

(1)  transient increase in muscle tone used in SOM (sphincter of Oddi manometry)

Secretin Stimulation Test SST


(1)  Exocrine pancreas dysfunction


(2)   Gastrinoma versus peptic ulcer disease


(3)   Identification of ampulla of Vater + accessory papilla during ERCP

Drug:   purified synthetic human secretin ChiRhoStim®, ChiRhoClin®

Dose:   0.2–0.4 µg/kg IV (~ 16 µg for adult) over 1 minute to avoid side effect of abdominal pain

Initial test dose:   for possible allergic reaction

Peak effect:   usually at 3–5 minutes after injection

√  ↑ main pancreatic duct (MPD) diameter by > 1 mm

√  ↑ visibility of side branches of MPD

√  ↑ T2 SI in duodenum ← excretion of pancreatic fluid

Adverse effects:   (in 0.5%) nausea, flushing, abdominal pain, vomiting, mild acute pancreatitis

Dx of gastrinoma:

release of gastrin from gastrinoma cells is increased → increased serum gastrin level of 200 ng/L above baseline (90% sensitive + specific)

N.B.:   normally secretin inhibits release of gastrin

Dx of chronic pancreatitis:

aspiration of intestinal secretions via tube passed into duodenum for 1 hour analyzing volume, pH, bicarbonate concentration in 15-minute aliquots (75% sensitive + 90% specific for chronic pancreatitis)

Contraindication:   acute pancreatitis

Somatostatin SS

=  growth hormone–inhibiting hormone (GHIH); somatotropin release-inhibiting factor (SRIF); somatotropin release-inhibiting hormone (SRIH)

Produced in:   many tissues; principally in nervous + digestive systems

Action:   inhibits secretion of several other hormones like growth hormone (GH), thyroid stimulating hormone (TSH), cholecystokinin, insulin

Released by:   raised levels of other hormones (feed back); ↑ blood glucose + amino acids (food intake)

Inhibited by:   reduced levels of other hormones (feed back)


@    Hypothalamus
inhibits pituitary gland → ↓ secretion of GH + TSH

Rx:  treatment of acromegaly

@    Pancreas
food intake → ↓ secretion of insulin + glucagon

@   GI tract

(a)  local reduction of gastric secretion

(b)  gastrointestinal motility

(c)  inhibits secretion of gastrin + secretin


Origin:   pouchlike extension of the yolk sac


(1)foregut supplied by celiac artery for bronchopulmo-nary system, stomach, pancreas, proximal duodenum


(2)midgut supplied by superior mesenteric artery (SMA) representing axis of gut rotation: mid-duodenum, jejunum, ileum, appendix, ascending colon, mid-transverse colon


(3)hindgut supplied by inferior mesenteric artery: mid-transverse colon, rectum

at 4 weeks:   short straight featureless tube

1st rotation:

(a)  duodenum rotates cephalocaudal 90° counterclockwise to a position at right of SMA

(b)  colon rotates 90° to left of SMA

at 6 weeks:   rapid growth of intraabdominal organs (expansion of liver + GI tract) → bowel herniates into umbilical cord = physiologic umbilical herniation

2nd rotation:

(a)  duodenum rotates another 90° (completes 180°) counter-clockwise beneath SMA to a position at left of SMA

(b)  colon does not rotate

at 10 weeks:   bowel returns to abdominal cavity

3rd rotation:

(a)  duodenum rotates another 90° (completes 270°) counter-clockwise with duodenojejunal junction resting to left of spine

(b)  colon rotates 180° counterclockwise until cecum is located in RLQ by 12th week

Peritoneal fixation of bowel:

›  broad-based mesentery extending from ligament of Treitz to ileocecal valve

›  colon fuses with retroperitoneum in RLQ with the exception of the most caudal part

›  duodenum fixes to retroperitoneum in LUQ

Change in fetal nutrition from yolk sac to placenta:

›  during 5th to 7th weeks → regressing omphalomesenteric duct


◊  Bowel receives 20% of resting cardiac output (²/³ for intestinal mucosa) which increases up to 35% in postprandial phase

Influence of food:

carbohydrates → earliest + fast rise

fat + proteins → slower + large rise

Celiac Trunk

Location:  at ~ T12 = superior border of pancreatic body

Supplies:  from distal esophagus to descending duodenum

Branches:  common hepatic a. (CHA), left gastric a. (LGA), splenic artery (SpA) with considerable variations in branching pattern

›  CHA branching from SMA (hepatomesenteric type)

›  direct branching of CHA / LGA / SpA from aorta

›  replaced left hepatic artery

›  replaced right hepatic artery

Anastomosis:   to SMA via gastroduodenal artery as the 1st branch off the celiac trunk

Superior Mesenteric Artery (SMA)

Supplies:  transverse + descending duodenum, jejunum, ileum, large bowel to splenic flexure

Anastomosis:   with IMA via marginal artery of Drummond, arcade of Riolan

Inferior Mesenteric Artery (IMA)

Supply for:   colon from splenic flexure to rectum

Anastomoses:   with lumbar branches of abdominal aorta, sacral artery, internal iliac arteries

Arterial Arcades

up to 4 arcades are formed by these arteries which continue toward the periphery as

1.   Primary parallel circuits for

a.   muscularis propria

b.   submucosa

c.   mucosa

2.   Serial circuits of

a.   resistance arterioles

b.   precapillary sphincters

c.   capillaries

d.   postcapillary sphincters

e.   venous capacitance vessels


Venae Rectae

=  multiple small veins along bowel wall that join to form venous arcades

Superior Mesenteric Vein

Drainage for:   small bowel, proximal colon to splenic angle

Formed by:   jejunoileal, ileocolic, right colic, middle colic, pancreaticoduodenal veins

Inferior Mesenteric Vein

Drainage for:   splenic flexure, descending colon, sigmoid colon, part of rectum

Formed by:   left colic, sigmoid, rectosigmoid, right and left superior rectal veins

Connects to:   SMV directly / splenic vein / angle of splenoportomesenteric confluence


Esophageal Division

1.   Upper third

cricopharyngeus to superior margin of aortic arch

2.   Middle third

superior margin of aortic arch to inferior pulmonary vein

3.   Lower third

inferior pulmonary vein to gastroesophageal junction

Cricopharyngeus Muscle

=  main component of upper esophageal sphincter

√  normally closed between swallows

√  relaxes and opens completely for bolus passage to occur in conjunction with elevation of larynx and pharyngeal constrictors

√  prominent posterior indentation on barium column ← incidental / sign of dysphagia

May be associated with:

pharyngeal constrictor muscle weakness, failure of laryngeal elevation, Zenker diverticulum, response esophageal spasm or GERD

Lower Esophageal Anatomy

A.  Esophageal Vestibule

=  saccular termination of lower esophagus with upper boundary at tubulovestibular junction + lower boundary at esophagogastric junction

√  collapsed during resting state

√  assumes bulbous configuration with swallowing

(a)  tubulovestibular junction = A level = junction between tubular and saccular esophagus

(b)  phrenic ampulla = bell-shaped part above diaphragm (term should be discarded because of dynamic changes of configuration)

(c)  submerged segment = infrahiatal part of esophagus

√  widening / disappearance is indicative of gastroesophageal reflux disease (GERD)

B.   Gastroesophageal Junction

Function:   regulates flow of food + fluid between esophagus and stomach; key defense against gastroesophageal reflux


(1)  Intrinsic smooth muscle of LES


(2)  Extrinsic striated muscle of crural diaphragm


(3)  clasp + sling fibers of gastric cardia

Site:   at upper level of gastric sling fibers, straddles cardiac incisura demarcating the left lateral margin of GE junction

C.  Z-line = B level = zigzag-shaped squamocolumnar junction line

◊  Not acceptable criterion for locating GE junction

Site:   1–2 cm above gastric sling fibers

D.  Lower Esophageal Sphincter

=  physiologic 2–4-cm high pressure zone corresponding to esophageal vestibule

√  tightly closed during resting state

√  assumes bulbous configuration with swallowing

Muscular Rings of Esophagus

A Ring

=  contracted / hypertrophied muscles in response to incompetent GE sphincter

•  rarely symptomatic / dysphagia

Location:   at tubulovestibular junction = superior aspect of vestibule

√  usually 2 cm proximal to GE junction at upper end of vestibule

√  varies in caliber during the same examination, may disappear on maximum distension

√  broad smooth narrowing with thick rounded margins

√  visible only if tubular esophagus above + vestibule below are distended

B Ring

=  sling fibers representing a U-shaped thickening of inner muscle layers with open arm of U toward lesser curvature = inferior aspect of vestibule

Location:   < 2 cm from hiatal margins

√  only visible when esophagogastric junction is above hiatus

√  thin ledge-like ring just below the mucosal junction (Z-line)

Layers of Intestinal Wall by Ultrasound

=  gut signature

1.   Mucosa  echogenic

√  hyperechoic interface of balloon + mucosa

2.   Muscularis mucosae  hypoechoic

√  hypoechoic mucosa + muscularis mucosa

3.   Submucosa  echogenic / hyperechoic

4.   Muscularis propria  hypoechoic

5.   Serosa  echogenic / hyperechoic

Most benign conditions preserve the gut signature involving long segments of bowel, while malignant conditions destroy the gut signature involving short segments of bowel.

Aggressive inflammatory processes cause focal disruption of the gut signature.


Preparation:   refrain from smoking for 12 hours + from eating for > 4 hours before examination

Provide info on baseline anatomy + swallow physiology: for oral cavity, pharynx, larynx, upper esophagus during deglutition


Videofluoroscopic Swallow Study (VFSS) = modified barium swallow study to assess handling of bolus; usually performed together with swallowing / speech pathologist

»  patient seated upright in lateral + AP positions

»  incremental increase in radiopaque bolus volume + texture of various consistencies like nectar liquid, honey liquid, pureed food, soft solid food, hard solid food (commercially available: E-Z Paque liquid, Varibar® thin liquid, nectar, honey, pudding, graham cracker cookie with pudding)

Document patient behavior + reaction:

episode of refusal, cough, silent aspiration, apnea, bradycardia

CNS involved:   cranial nerves V, VII, IX, X, XII; 5 cervical nerves; cortical + subcortical pathways; midbrain; brainstem

Muscles involved:   32 groups of muscles

Developmental:      swallowing as early as 11 weeks GA;
suckling at 18–24 weeks GA; nonnutritive
sucking at 27–28 weeks GA; single breath
sucking at 35–36 weeks GA


1.   Oral preparatory phase

√  food chewed + mixed with saliva

2.   Oral phase

√  bolus propelled posteriorly to tongue


(a)  spillage from mouth

(b)  small bolus formation

(c)  tongue tremor

(d)  incomplete tongue elevation

(e)  early spillage into valleculae prior to initiation of swallow

3.   Pharyngeal phase

√  elevation of soft palate + valleculae (to seal nasopharynx)

√  elevation of larynx (to close vestibule)

√  relaxation of cricopharyngeal muscle

√  contraction of lateral pharyngeal wall

At videofluoroscopy carefully evaluate mechanisms to prevent aspiration: superior + anterior elevation of larynx, closure of larynx, and epiglottic tilt.


(a)  nasopharyngeal reflux

(b)  laryngeal penetration = contrast material enters laryngeal vestibule

Cause:   delayed elevation of larynx

(c)  tracheal aspiration = contrast material enters airway below vocal cord level into proximal trachea

Cause:   delayed elevation of larynx, delayed pharyngeal transit time, decreased clearance of bolus with residual in vallecula and pyriform sinus spilling into larynx + trachea

4.   Esophageal phase

√  contraction of cricopharyngeal muscle

√  bolus transfer into esophagus

Path:   cricopharyngeal achalasia (with reflux of bolus into oropharynx / pooling in pyriform sinus)


Segmental Anatomy of Stomach

1.   Cardia

2.   Fundus

Dependency:   most superior portion when upright most dependent portion when supine

√  stomach bubble on CXR

√  accumulation of intraluminal contents on CT

3.   Body

(a)  lesser curvature: left and posteriorly on CT

(b)  greater curvature: right and anteriorly on CT

√  ≤ 5 mm in thickness (in distended state)

»  Incisura angularis

=  transition to antral-type mucosa

◊  Most common site for gastric ulcers!

4.   Antrum

=  thickest gastric segment ← most muscular

√  ≤ 12 mm in thickness (in distended state)

√  exhibits the most peristalsis

√   may display mural stratification on CECT

5.   Pylorus

Inadequate gastric distention limits diagnostic evaluation and may create a false appearance of thickening or may obscure true disease.

When evaluating abnormal gastric wall thickening in a nondistended stomach, supplementary findings can be helpful in identifying disease.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 29, 2017 | Posted by in GENERAL RADIOLOGY | Comments Off on and Function of Abdomen and Gastrointestinal Tract

Full access? Get Clinical Tree

Get Clinical Tree app for offline access